Christina Chakarova
UCL Institute of Ophthalmology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christina Chakarova.
Nature Reviews Genetics | 2010
Alan F. Wright; Christina Chakarova; Mai M. Abd El-Aziz; Shomi S. Bhattacharya
The retina provides exquisitely sensitive vision that relies on the integrity of a uniquely vulnerable cell, the photoreceptor (PR). The genetic and mechanistic causes of retinal degeneration due to PR cell death — which occurs in conditions such as retinitis pigmentosa and age-related macular degeneration — are being successfully dissected. Over one hundred loci, some containing common variants but most containing rare variants, are implicated in the genetic architecture of this complex trait. This genetic heterogeneity results in equally diverse disease mechanisms that affect almost every aspect of PR function but converge on a common cell death pathway. Although genetic and mechanistic diversity creates challenges for therapy, some approaches — particularly gene-replacement therapy — are showing considerable promise.
Molecular Cell | 2001
Eranga N. Vithana; Leen Abu-Safieh; Maxine Allen; Alisoun H. Carey; Myrto Papaioannou; Christina Chakarova; Mai Al-Maghtheh; Neil D. Ebenezer; Catherine Willis; Anthony T. Moore; Alan C. Bird; David M. Hunt; Shomi S. Bhattacharya
We report mutations in a gene (PRPF31) homologous to Saccharomyces cerevisiae pre-mRNA splicing gene PRP31 in families with autosomal dominant retinitis pigmentosa linked to chromosome 19q13.4 (RP11; MIM 600138). A positional cloning approach supported by bioinformatics identified PRPF31 comprising 14 exons and encoding a protein of 499 amino acids. The level of sequence identity to the yeast PRP31 gene indicates that PRPF31 is also likely to be involved in pre-mRNA splicing. Mutations that include missense substitutions, deletions, and insertions have been identified in four RP11-linked families and three sporadic RP cases. The identification of mutations in a pre-mRNA splicing gene implicates defects in the splicing process as a novel mechanism of photoreceptor degeneration.
Nature Genetics | 2009
Hemant Khanna; Erica E. Davis; Carlos A. Murga-Zamalloa; Alejandro Estrada-Cuzcano; Irma Lopez; Anneke I. den Hollander; Marijke N Zonneveld; Mohammad Othman; Naushin Waseem; Christina Chakarova; Cecilia Maubaret; Anna Diaz-Font; Ian M. MacDonald; Donna M. Muzny; David A. Wheeler; Margaret Morgan; Lora Lewis; Clare V. Logan; Perciliz L. Tan; Michael Beer; Chris F. Inglehearn; Richard Alan Lewis; Samuel G. Jacobson; Carsten Bergmann; Philip L. Beales; Tania Attié-Bitach; Colin A. Johnson; Edgar A. Otto; Shomi S. Bhattacharya; Friedhelm Hildebrandt
Despite rapid advances in the identification of genes involved in disease, the predictive power of the genotype remains limited, in part owing to poorly understood effects of second-site modifiers. Here we demonstrate that a polymorphic coding variant of RPGRIP1L (retinitis pigmentosa GTPase regulator-interacting protein-1 like), a ciliary gene mutated in Meckel-Gruber (MKS) and Joubert (JBTS) syndromes, is associated with the development of retinal degeneration in individuals with ciliopathies caused by mutations in other genes. As part of our resequencing efforts of the ciliary proteome, we identified several putative loss-of-function RPGRIP1L mutations, including one common variant, A229T. Multiple genetic lines of evidence showed this allele to be associated with photoreceptor loss in ciliopathies. Moreover, we show that RPGRIP1L interacts biochemically with RPGR, loss of which causes retinal degeneration, and that the Thr229-encoded protein significantly compromises this interaction. Our data represent an example of modification of a discrete phenotype of syndromic disease and highlight the importance of a multifaceted approach for the discovery of modifier alleles of intermediate frequency and effect.
Nature Genetics | 2012
Marni J. Falk; Qi Zhang; Eiko Nakamaru-Ogiso; Chitra Kannabiran; Zoë D. Fonseca-Kelly; Christina Chakarova; Isabelle Audo; Donna S. Mackay; Christina Zeitz; Arundhati Dev Borman; Magdalena Staniszewska; Rachna Shukla; Lakshmi Palavalli; Saddek Mohand-Said; Naushin Waseem; Subhadra Jalali; Juan C. Perin; Emily Place; Julian Ostrovsky; Rui Xiao; Shomi S. Bhattacharya; Mark Consugar; Andrew R. Webster; José-Alain Sahel; Anthony T. Moore; Eliot L. Berson; Qin Liu; Xiaowu Gai; Eric A. Pierce
Leber congenital amaurosis (LCA) is an infantile-onset form of inherited retinal degeneration characterized by severe vision loss. Two-thirds of LCA cases are caused by mutations in 17 known disease-associated genes (Retinal Information Network (RetNet)). Using exome sequencing we identified a homozygous missense mutation (c.25G>A, p.Val9Met) in NMNAT1 that is likely to be disease causing in two siblings of a consanguineous Pakistani kindred affected by LCA. This mutation segregated with disease in the kindred, including in three other children with LCA. NMNAT1 resides in the previously identified LCA9 locus and encodes the nuclear isoform of nicotinamide mononucleotide adenylyltransferase, a rate-limiting enzyme in nicotinamide adenine dinucleotide (NAD+) biosynthesis. Functional studies showed that the p.Val9Met alteration decreased NMNAT1 enzyme activity. Sequencing NMNAT1 in 284 unrelated families with LCA identified 14 rare mutations in 13 additional affected individuals. These results are the first to link an NMNAT isoform to disease in humans and indicate that NMNAT1 mutations cause LCA.
Nature Genetics | 2008
Mai M. Abd El-Aziz; Isabel Barragan; Ciara A. O'Driscoll; Leo Goodstadt; Elena Prigmore; Salud Borrego; Marcela Mena; Juan Ignacio Pieras; Mohamed F. El-Ashry; Leen Abu Safieh; Amna Z. Shah; Michael E. Cheetham; Nigel P. Carter; Christina Chakarova; Chris P. Ponting; S.S. Bhattacharya; Guillermo Antiñolo
Using a positional cloning approach supported by comparative genomics, we have identified a previously unreported gene, EYS, at the RP25 locus on chromosome 6q12 commonly mutated in autosomal recessive retinitis pigmentosa. Spanning over 2 Mb, this is the largest eye-specific gene identified so far. EYS is independently disrupted in four other mammalian lineages, including that of rodents, but is well conserved from Drosophila to man and is likely to have a role in the modeling of retinal architecture.
American Journal of Human Genetics | 2006
James S. Friedman; Bo Chang; Chitra Kannabiran; Christina Chakarova; Hardeep Pal Singh; Subhadra Jalali; Norman L. Hawes; Kari Branham; Mohammad Othman; E. Filippova; Debra A. Thompson; Andrew R. Webster; Sten Andréasson; Samuel G. Jacobson; Shomi S. Bhattacharya; John R. Heckenlively; Anand Swaroop
The rd3 mouse is one of the oldest identified models of early-onset retinal degeneration. Using the positional candidate approach, we have identified a C-->T substitution in a novel gene, Rd3, that encodes an evolutionarily conserved protein of 195 amino acids. The rd3 mutation results in a predicted stop codon after residue 106. This change is observed in four rd3 lines derived from the original collected mice but not in the nine wild-type mouse strains that were examined. Rd3 is preferentially expressed in the retina and exhibits increasing expression through early postnatal development. In transiently transfected COS-1 cells, the RD3-fusion protein shows subnuclear localization adjacent to promyelocytic leukemia-gene-product bodies. The truncated mutant RD3 protein is detectable in COS-1 cells but appears to get degraded rapidly. To explore potential association of the human RD3 gene at chromosome 1q32 with retinopathies, we performed a mutation screen of 881 probands from North America, India, and Europe. In addition to several alterations of uncertain significance, we identified a homozygous alteration in the invariant G nucleotide of the RD3 exon 2 donor splice site in two siblings with Leber congenital amaurosis. This mutation is predicted to result in premature truncation of the RD3 protein, segregates with the disease, and is not detected in 121 ethnically matched control individuals. We suggest that the retinopathy-associated RD3 protein is part of subnuclear protein complexes involved in diverse processes, such as transcription and splicing.
American Journal of Human Genetics | 2009
James S. Friedman; Joseph W. Ray; Naushin Waseem; Kory R. Johnson; Matthew Brooks; Therése Hugosson; Debra K. Breuer; Kari Branham; Daniel S. Krauth; Sara J. Bowne; Lori S. Sullivan; Vesna Ponjavic; Lotta Gränse; Ritu Khanna; Edward H. Trager; Linn Gieser; Dianna Hughbanks-Wheaton; Radu Cojocaru; Noor M. Ghiasvand; Christina Chakarova; Magnus Abrahamson; Harald H H Göring; Andrew R. Webster; David G. Birch; Gonçalo R. Abecasis; Yang C. Fann; Shomi S. Bhattacharya; Stephen P. Daiger; John R. Heckenlively; Sten Andréasson
Retinitis pigmentosa (RP) refers to a genetically heterogeneous group of progressive neurodegenerative diseases that result in dysfunction and/or death of rod and cone photoreceptors in the retina. So far, 18 genes have been identified for autosomal-dominant (ad) RP. Here, we describe an adRP locus (RP42) at chromosome 7p15 through linkage analysis in a six-generation Scandinavian family and identify a disease-causing mutation, c.449G-->A (p.S150N), in exon 6 of the KLHL7 gene. Mutation screening of KLHL7 in 502 retinopathy probands has revealed three different missense mutations in six independent families. KLHL7 is widely expressed, including expression in rod photoreceptors, and encodes a 75 kDa protein of the BTB-Kelch subfamily within the BTB superfamily. BTB-Kelch proteins have been implicated in ubiquitination through Cullin E3 ligases. Notably, all three putative disease-causing KLHL7 mutations are within a conserved BACK domain; homology modeling suggests that mutant amino acid side chains can potentially fill the cleft between two helices, thereby affecting the ubiquitination complexes. Mutations in an identical region of another BTB-Kelch protein, gigaxonin, have previously been associated with giant axonal neuropathy. Our studies suggest an additional role of the ubiquitin-proteasome protein-degradation pathway in maintaining neuronal health and in disease.
American Journal of Human Genetics | 2007
Christina Chakarova; Myrto Papaioannou; Hemant Khanna; Irma Lopez; Naushin Waseem; Amna Z. Shah; Torsten Theis; James S. Friedman; Cecilia Maubaret; Kinga Bujakowska; Brotati Veraitch; Mai M. Abd El-Aziz; De Quincy Prescott; Sunil K. Parapuram; Wendy A. Bickmore; Peter M.G. Munro; Andreas Gal; Christian P. Hamel; Valeria Marigo; Chris P. Ponting; Bernd Wissinger; Eberhart Zrenner; Karl Matter; Anand Swaroop; Robert K. Koenekoop; Shomi S. Bhattacharya
We report mutations in the gene for topoisomerase I-binding RS protein (TOPORS) in patients with autosomal dominant retinitis pigmentosa (adRP) linked to chromosome 9p21.1 (locus RP31). A positional-cloning approach, together with the use of bioinformatics, identified TOPORS (comprising three exons and encoding a protein of 1,045 aa) as the gene responsible for adRP. Mutations that include an insertion and a deletion have been identified in two adRP-affected families--one French Canadian and one German family, respectively. Interestingly, a distinct phenotype is noted at the earlier stages of the disease, with an unusual perivascular cuff of retinal pigment epithelium atrophy, which was found surrounding the superior and inferior arcades in the retina. TOPORS is a RING domain-containing E3 ubiquitin ligase and localizes in the nucleus in speckled loci that are associated with promyelocytic leukemia bodies. The ubiquitous nature of TOPORS expression and a lack of mutant protein in patients are highly suggestive of haploinsufficiency, rather than a dominant negative effect, as the molecular mechanism of the disease and make rescue of the clinical phenotype amenable to somatic gene therapy.
Human Molecular Genetics | 2011
Christina Chakarova; Hemant Khanna; Amna Z. Shah; Suresh B. Patil; Tina Sedmak; Carlos A. Murga-Zamalloa; Myrto Papaioannou; Kerstin Nagel-Wolfrum; Irma Lopez; Peter M.G. Munro; Michael E. Cheetham; Robert K. Koenekoop; Rosa M. Rios; Karl Matter; Uwe Wolfrum; Anand Swaroop; Shomi S. Bhattacharya
We recently reported that mutations in the widely expressed nuclear protein TOPORS (topoisomerase I-binding arginine/serine rich) are associated with autosomal dominant retinal degeneration. However, the precise localization and a functional role of TOPORS in the retina remain unknown. Here, we demonstrate that TOPORS is a novel component of the photoreceptor sensory cilium, which is a modified primary cilium involved with polarized trafficking of proteins. In photoreceptors, TOPORS localizes primarily to the basal bodies of connecting cilium and in the centrosomes of cultured cells. Morpholino-mediated silencing of topors in zebrafish embryos demonstrates in another species a comparable retinal problem as seen in humans, resulting in defective retinal development and failure to form outer segments. These defects can be rescued by mRNA encoding human TOPORS. Taken together, our data suggest that TOPORS may play a key role in regulating primary cilia-dependent photoreceptor development and function. Additionally, it is well known that mutations in other ciliary proteins cause retinal degeneration, which may explain why mutations in TOPORS result in the same phenotype.
Investigative Ophthalmology & Visual Science | 2009
Kinga Bujakowska; Cecilia Maubaret; Christina Chakarova; Naoyuki Tanimoto; Susanne C. Beck; Edda Fahl; Marian M. Humphries; Paul F. Kenna; Evgeny M. Makarov; Olga V. Makarova; François Paquet-Durand; Per Ekström; Theo van Veen; Thierry Léveillard; Peter Humphries; Mathias W. Seeliger; Shomi S. Bhattacharya
PURPOSE Pre-mRNA processing factor 31 (PRPF31) is a ubiquitous protein needed for the assembly of the pre-mRNA splicing machinery. It has been shown that mutations in this gene cause autosomal dominant retinitis pigmentosa 11 (RP11), which is characterized by rod-cell degeneration. Interestingly, mutations in this ubiquitously expressed gene do not lead to phenotypes other than retinal malfunction. Furthermore, the dominant inheritance pattern has shown incomplete penetrance, which poses interesting questions about the disease mechanism of RP11. METHODS To characterize PRPF31 function in the rod cells, two animal models have been generated. One was a heterozygous knock-in mouse (Prpf31(A216P/+)) carrying a point mutation p.A216P, which has previously been identified in RP11 patients. The second was a heterozygous knockout mouse (Prpf31(+/-)). Retinal degeneration in RP11 mouse models was monitored by electroretinography and histology. RESULTS Generation of the mouse models is presented, as are results of ERGs and retinal morphology. No degenerative phenotype on fundus examination was found in Prpf31(A216P/+) and Prpf31(+/-) mice. Prpf31(A216P/A216P) and Prpf31(-/-) genotypes were embryonic lethal. CONCLUSIONS The results imply that Prpf31 is necessary for survival, and there is no compensation mechanism in mouse for the lack of this splicing factor. The authors suggest that p.A216P mutation in Prpf31 does not exert a dominant negative effect and that one Prpf31 wild-type allele is sufficient for maintenance of the healthy retina in mice.